Introduction
Ca 2+ -regulated photoprotein obelin, like other coelenterate photoproteins, is a stable complex of a single-chain apoprotein and peroxycoelenterazine. Upon binding of Ca 2+ , obelin undergoes a conformation change that causes the decarboxylation of peroxycoelenterazine and the emission of visible light (l max ¼ 482 nm). 1, 2 The relationship between the light emission and the amount of obelin is linear in the presence of an excess of Ca 2+ . A high quantum yield of the reaction, virtual absence of the background, and high sensitivity of modern photometers make it possible to detect the photoprotein down to the attomole level. The recently developed analytical techniques use Ca 2+ -regulated photoproteins aequorin and obelin as effective reporters. 3 Binding assays involving these bioluminescent reporters provide high sensitivity, simplicity of measurement, reproducibility and safety. With the application of site-directed mutagenesis, obelin mutants with substantially altered bioluminescence spectral and kinetic characteristics were obtained in our laboratory: W92F,H22E emits a fast (k d ¼ 0.6 s À1 ) violet signal (l max ¼ 387 nm) and Y138F -a slow (k d ¼ 6.1 s À1 ) greenish light (l max ¼ 498 nm) with small spectral overlapping.
4
Using these as reporters, we developed a dual analyte single-well bioluminescence assay based on the spectral resolution of signals, in combination with time resolution. The technique allows enhancement of the assay capability for the sake of proper diagnostics, especially in cases requiring the detection of two analytes in one sample. Recently, we successfully applied the approach to the simultaneous immunoassay of two forms of prolactin, the total and IgG-bound ones, in crude serum. 5 It was performed in a microplate format and allowed the detection of the two prolactin forms without any additional manipulation. The assay provided a high sensitivity in detecting total prolactin, close to that of RIA, and a capability to visualize both prolactin forms like in the case of gel-ltration chromatography, but in a much shorter time.
In this study, the application of our approach was broadened to: (a) simultaneous immunoassay of two gonadotropic hormones -luteinizing (lutropin or hLH) and follicle stimulating (hFSH) -in clinical sera, and (b) simultaneous detection of two gene allelic variants at SNP genotyping of the human F5 gene encoding factor V Leiden polymorphism 1691 G/A (R506Q). Many clinical samples were investigated and the obtained results were in good correlation with those obtained by traditional techniques.
Experimental

Materials
The highly puried photoproteins (violet mutant W92F,H22E and green mutant Y138F of obelin) were obtained according to ref. 4 . Streptavidin, 2-iminothiolan, N-succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) were from Sigma (USA).
Monoclonal mouse anti-hLH IgG (clone 5301) and antihFSH IgG (clone 6602) were from MedixBiochemica (Finland); monoclonal mouse anti-hLH/hFSH (a-chain) IgG (clone XF-1) -from Xema-Medica (Russia); goat polyclonal anti-FITC IgGfrom Abcam (UK To obtain the W92F,H22E-(dT) 30 conjugate, the protein was incubated with a 5-fold excess of 2-iminothiolan in 50 mM BICINE pH 8.5, 5 mM EDTA for 30 min at room temperature. Excess of reagent was removed by gel ltration on a D-salt Dextran Desalting column (Pierce, USA) equilibrated with 50 mM PIPES pH 7.5, 5 mM EDTA. The NH 2 -dT 30 was modied by a 100-fold excess of SMCC in 0.1 M NaHCO 3 for 2 h at room temperature followed by removal of excess reagent on a Sephadex G-25 spin-column equilibrated with water. The mixture of thionylated W92F,H22E and SMCC-activated oligonucleotide (molar ratio 2 : 1) was incubated overnight at 8 C.
The conjugate W92F,H22E-(dT) 30 was puried on a Mono Q column (GE Healthcare, Sweden) equilibrated with 20 mM TrisHCl pH 7.0, 5 mM EDTA using gradient 1 M NaCl up to 70%. All conjugates were stored at À18 C in 20 mM Tris-HCl pH 7.0, 0.25 M NaCl, 5 mM EDTA, 0.1% BSA over 1 year without loss of bioluminescent activity. Solid-phase immunoassay was carried out using white polystyrene stripwell microtiter plates (Corning, USA). In dual color assays, the photometer registered signals through bandpass optical lters VB6 (I) and YB16 (II) (Len-ZOS, Russia). Sera samples were provided by the endocrinology diagnostic laboratory of Krasnoyarsk regional hospital no. 1. The hLH and hFSH in sera were previously quantied with separate RIA.
DNA samples were analyzed earlier by other methods and provided by Krasnoyarsk Branch of Hematological Scientic Center of the Russian Academy of Medical Sciences.
Simultaneous microtiter-based bioluminescent immunoassay of LH and FSH. The surface of wells was activated with 100 mL of mouse anti-hLH/hFSH (a-chain) (clone XF-1) immunoglobulin solution, 10 mg mL À1 , in PBS (0.15 M NaCl, 50 mM K-Na phosphate buffer pH 7.0) overnight at 4 C. Then it was washed (three times, PBS, 0.1% Tween 20, 5 mM EDTA) and blocked by placing 1% BSA in PBS (140 mL per well) for 1 h, 37 C. Aer washing, 100 mL standard (three replicates) and clinical (two replicates) sera were placed into the wells, incubated with shaking for 1 h at 37 C and washed thereaer. Then the mixture of conjugates -W92F,H22E-anti-hLH IgG (clone 5301) and Y138F-anti-hFSH IgG (clone 6602) (100 mL, 1 mg mL À1 each, PBS, 0.1% BSA, 5 mM EDTA) -was placed into the wells, incubated with shaking for 1 h at 23 C and washed thereaer. PEXT products microplate assay. The surface of the wells was activated with 50 mL of streptavidin solution, 10 mg mL À1 , in PBS for 1 h at 37 C with shaking. Aer washing (three times, PBS, 0.1% Tween 20, 5 mM EDTA) the PEXT products (3 mL) in hybridization buffer (47 mL) containing 0.1 M maleic acid, 0.15 M NaCl, 5 mM EDTA, and 1% BSA were placed into the wells and incubated for 30 min at room temperature. The wells were washed again and the mixture of conjugates, Y138F-anti-FITC IgG and W92F,H22E-(dT) 30 (50 mL, each 0.1 mg mL
À1
, in 20 mM Tris-HCl pH 7.0, 5 mM EDTA, 0.1 M NaCl, 0.1% BSA), was placed into the wells, incubated with shaking for 30 min at room temperature and washed thereaer. The bioluminescence intensity was measured with a plate luminometer LB 940 Multimode Reader Mithras by rapid injection of CaCl 2 solution into the well plate as was described above, excepting the green signal integrated for 3 seconds.
Results and discussion
Two kinds of the mutant of Ca 2+ -regulated photoprotein obelin recently obtained in our laboratory 4 are characterized by their distinct difference in bioluminescence. The emission maxima of mutants W92F,H22E (violet) and Y138F (green) are separated by 113 nm with a small spectral overlap. It is possible to exploit this wide separation by the use of two wide band-pass optical lters (Fig. 1, inset) . Because the bioluminescence kinetics of the green obelin is 10-fold slower than that of the violet obelin, the difference provides the possibility to resolve the signals in time. To implement the separation methods, we applied a plate luminometer Mithras LB 940. The construction of this device facilitates luminescence measurement through the optical lters placed on the wheel that allows fast lter replacement. Fig. 1 shows the bioluminescent reaction of the protein mixture. To divide signals effectively, a fast-kinetic violet signal was registered through optical lter I for 1 s, and a long-kinetic green signal -through optical lter II for 3-5 seconds. Filter replacement was done automatically for 0.3 seconds.
Human luteinizing hormone (lutropin or hLH) and follicle stimulating hormone (hFSH) belong to a subset of glycoprotein hormones, called gonadotropins that regulate gonadal function. Immunoassay is a useful tool for estimating the hormone levels in serum, and is important for discovering the disorders related to reproduction and puberty, such as hypogonadism, ovulation timing, and infertility. For proper diagnosis, it is strongly recommended to measure the levels of both hormones. The hLH and hFSH contain two different subunits, an a-and a b-chain, linked by noncovalent bonds. The primary structures of the a-subunits are almost identical, while their b-subunits are not identical. The b-subunits are responsible for the immunological and biological specicity of these hormones. Fig. 2A presents the way we carried out the assay. The surface of wells was activated with immunoglobulin Ab1 (anti-hLH/ hFSH, a-chain), then the samples of standard or clinical sera were placed into the wells, incubated and washed. The mixture of Y138F-Ab2 (anti-hFSH immunoglobulin) and W92F,H22E-Ab3 (anti-hLH immunoglobulin) conjugates was placed into the wells, incubated and washed thereaer. The violet label got bound with the hLH b-subunit, whereas the green one bound with the hFSH b-subunit. Bioluminescence of both labels was triggered by Ca 2+ injection and measured sequentially: during the rst second the violet signal was integrated through lter I, and aer lter replacement the green signal was measured for 5 seconds. Fig. 2B gives the typically obtained results. The assay (in triplicate) of standard sera was performed in wells A1-C7. These samples are articial sera, containing hLH and hFSH of a given equal concentration. The dependences of the violet bioluminescent signal upon hLH concentration and the green signal upon hFSH concentration (Fig. 2C and D) are linear for the whole concentration range, with R 2 ¼ 0.999 and R 2 ¼ 0.997, respectively. The hLH and hFSH bioluminescence assay sensitivities were 0.4 mU mL À1 and 0.34 mU mL À1 respectively (calculated from three replicates of standard zero sera assay, as mean + 2 standard deviation). These are close to sensitivities of separate radioisotope immunoassay -0.34 mU mL À1 for hLH and 0.28 for hFSH (diagnostic kit from DIAS Ltd, Russia), and colorimetric immunoassay (0.3 mU mL À1 , diagnostic kit from XEMA, Russia). Using these dependence data as calibration curves, we determined the hLH and hFSH concentrations in 71 clinical sera. Some sera assays (in duplicate each) are presented in wells D1-H7. The data demonstrate good correlation between the proposed simultaneous bioluminescent assay and the traditional separate RIA (Fig. 2E and F Another type of assay requiring detection of two targets (two gene allelic variants) is single nucleotide polymorphism (SNP) genotyping. We developed the method for SNP identication based on the primer extension reaction (PEXT) 7 followed by simultaneous alleles detection with bioluminescent solid-phase microassay. The study was performed as an example of SNP genotyping factor V Leiden polymorphism 1691 G/A (R506Q) in the gene encoding coagulation factor V. Identication of this polymorphism has prognostic value, which allows one to estimate the risk of cardiovascular diseases caused by blood clotting disorders and cardiovascular abnormalities in offspring. Coagulation factor V is the protein cofactor in the formation of thrombin from prothrombin. Mutation confers the resistance to the active form of factor V against proteolytic action of the regulating enzyme (activated protein C), which leads to hypercoagulation. Carriers of variant A have an increased propensity to vascular thrombosis, which represents a risk factor for venous and arterial thromboembolism, myocardial infarction, and stroke. This polymorphism is diagnostically valuable and widely analyzed in laboratory diagnostics.
Specially selected DNA samples analyzed earlier by other methods were taken for the investigation. Genomic DNA was amplied by PCR using primers anking a polymorphic site of 140 base pairs (dbSNP: rs6025). PCR products were used as templates for PEXT reaction with two primers containing 3 0 -terminal nucleotides, which were complementary to either normal or mutant alleles (Fig. 3A) . The primer complementary to the normal allele was labeled with 6-carboxyuorescein (FAM), the other with oligoadenylate (dA) 27 . The reactions were carried out in the same tube. If the template and allele-specic primer were completely complementary, the latter was elongated with DNA polymerase. The resulting extension product contained a biotin residue due to the presence of biotinylated deoxyuridine triphosphate (B-dUTP) in the reaction mixture. The products were analyzed by solid-phase microassay in the same microtiter well according to the scheme presented in Fig. 3B . Biotin-containing oligonucleotides were immobilized on the streptavidin-activated well surface. Then the conjugate mixture (violet obelin-oligothymidylate and green obelin-anti-FAM IgG) was placed into the wells, incubated and washed. Obelins' bioluminescent reaction was initiated by Ca 2+ and measured as was described above. The green signal is associated with the normal allele, while the violet one is associated with mutant allele availability. The genotype for each sample is dened by the ratio of the bioluminescent signals. Fig. 3C Reproducibility of the method was evaluated from the results of triplicate analysis (PCR of genomic DNA, PEXT reaction, and bioluminescent analysis of the reaction products) of two DNA samples of G/A and G/G genotypes. The variation coefficient of the discrimination factor (BL N /BL M ) was 10.5% for the heterozygous G/A genotype and 14.4% for the normal G/G genotype.
There are no essential changes in the discrimination factor over a broad range of amplied DNA amount in PEXT reactions. So at assaying 10, 25, 50, 100 and 200 fmol of amplied DNA, the average discrimination factor values were 15.4 AE 2.85 and 1.58 AE 0.45 for G/A and G/G genotype samples, respectively.
Conclusion
In the present study, we have successfully applied two obelin mutants for simultaneous detection of two analytes in a single well, based on the spectral and time resolutions of bioluminescent signals. Both ash-type signals were triggered by a single injection of Ca 2+ -no other substrates or co-factors were required. The total registration took only 4-6 s, despite the fact that the bioluminescence of labels was integrated sequentially. This distinguishes the proposed approach from the two-target simultaneous assays involving two different labels [e.g. see ref. [8] [9] [10] . We see obvious reasons for applying this technique in any dual assay regardless of its type -immune, hybridization or both. It is useful for large-scale research, and provides a fast and sensitive two-target assay that overcomes shortcomings of separate determination, in addition to the advantages in terms of cost and labor savings.
